The company was founded in July 2003 and restructured as a limited company in February 2010; listed on the Shenzhen Stock Exchange GEM in September 2011. The company is mainly engaged in the development and production of plant protection products, pharmaceutical intermediates and nutritional health products. The company currently has seven production bases and three R&D centers. The company is mainly engaged in R&D, production and sales of pharmaceutical and pesticide intermediate products. Main products: chloramphenicamide intermediates, trifluorophenylpyrimidine intermediates, trifluoroimidamide intermediates, tetrazolamide intermediates, indacarboxil intermediates, fluthiazolepiacetone intermediates, polyazolidone preparations, BAZI intermediates, CAZI intermediates, sitagliptin hydrochloride APIs, praxol raw materials, palipiperidone intermediates, cistastatin intermediates, durutevir intermediates, enzyme preparations, NMN. Corporate honors: “2018 China's Top 100 Fine Chemical Manufacturing Enterprises” won the 36th place, China's pharmaceutical and health products import and export ranking of the top 50 API export companies in 2017, and won the first prize of the Shanghai Science and Technology Progress Award, etc.
No Data